Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BerGenBio ASA (BRRGF)
OTHER OTC:BRRGF
Holding BRRGF?
Track your performance easily
BRRGF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.03 - $0.14
Previous Close$0.03
Volume37.30K
Average Volume (3M)N/A
Market Cap
$41.32M
Enterprise Value$449.14M
Total Cash (Recent Filing)kr0.00
Total Debt (Recent Filing)kr407.83M
Price to Earnings (P/E)―
Beta0.28
Next Earnings
Nov 13, 2024EPS Estimate
-$0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.50
Shares Outstanding88,660,532
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.63
R-Squared0.00457
Alpha0.00951
Financial Highlights & Ratios
Price to Book (P/B)1.14
Price to Sales (P/S)243.19
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$3.63Price Target Upside45.20% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
BerGenBio ASA News
PremiumCompany Announcements
BerGenBio Solidifies Clinical Trials and Finances
PremiumCompany Announcements
BerGenBio Partners with Tempus on Cancer Treatment
PremiumCompany Announcements
BerGenBio Completes Share Capital Reduction
PremiumCompany Announcements
BerGenBio ASA Announces Upcoming Financial Results
PremiumCompany Announcements
BerGenBio Advances with Phase 2a NSCLC TrialPremiumCompany Announcements
BerGenBio Advances in Lung Cancer TherapyOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
1.80% Mutual Funds
<0.01% Other Institutional Investors
98.20% Public Companies and
Individual Investors
BRRGF FAQ
What was BerGenBio ASA’s price range in the past 12 months?
BerGenBio ASA lowest stock price was $0.03 and its highest was $0.14 in the past 12 months.
What is BerGenBio ASA’s market cap?
Currently, no data Available
When is BerGenBio ASA’s upcoming earnings report date?
BerGenBio ASA’s upcoming earnings report date is Nov 13, 2024 which is in 73 days.
How were BerGenBio ASA’s earnings last quarter?
BerGenBio ASA released its earnings results on Aug 21, 2024. The company reported -$0.132 earnings per share for the quarter, missing the consensus estimate of -$0.119 by -$0.013.
Is BerGenBio ASA overvalued?
According to Wall Street analysts BerGenBio ASA’s price is currently Undervalued.
Does BerGenBio ASA pay dividends?
BerGenBio ASA does not currently pay dividends.
What is BerGenBio ASA’s EPS estimate?
BerGenBio ASA’s EPS estimate is -$0.13.
How many shares outstanding does BerGenBio ASA have?
BerGenBio ASA has 39,087,116 shares outstanding.
What happened to BerGenBio ASA’s price movement after its last earnings report?
BerGenBio ASA reported an EPS of -$0.132 in its last earnings report, missing expectations of -$0.119. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of BerGenBio ASA?
Currently, no hedge funds are holding shares in BRRGF
---
BerGenBio ASA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-69.87%
12-Months-Change
Fundamentals
Return on Equity
-85.63%
Trailing 12-Months
Asset Growth
-8.58%
Trailing 12-Months
Company Description
BerGenBio ASA
BerGenBio ASA is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is in clinical development as a novel treatment for a variety of cancers.
---
BRRGF Company Deck
---
BRRGF Earnings Call
Q2 2024
0:00 / 0:00
---
BRRGF Stock 12 Month Forecast
Average Price Target
$3.63
▲(45.20% Upside)
Technical Analysis
Best Analysts Covering BRRGF
1 Year
1 Year Success Rate
0/10 ratings generated profit
1 Year Average Return
-34.90%
reiterated a buy rating 11 days ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -34.90% per trade.
---